Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global genomic biomarkers market, 2014 2022 (USD Billion)
2.2. Global genomic biomarkers market : Snapshot
Chapter 3. Genomic Biomarkers Market Dynamics
3.1. Introduction
3.2. Market drivers
3.2.1. Global genomic biomarkers market drivers: Impact analysis
3.2.2. Increasing prevalence of cardiovascular diseases, cancer, neurological disorders across the globe
3.2.3. Rising need for genomic biomarker based personalized medicines
3.3. Market restraints
3.3.1. Global Genomic biomarkers market restraints: Impact analysis
3.3.2. Stringent government regulations
3.4. Opportunities
3.4.1. Increasing adoption of personalized medicines
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. Threat from new entrants
3.5.4. Threat from new substitutes
3.5.5. Degree of competition
3.6. Market attractiveness analysis
3.6.1. Market attractiveness analysis, by indication segment
3.6.2. Market attractiveness analysis, by end user segment
3.6.3. Market attractiveness analysis, by regional segment
Chapter 4. Global Genomic Biomarkers Market Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global genomic biomarkers market: company market share, 2015
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Product Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Regional Expansion
Chapter 5. Global Genomic Biomarkers Market Indication Segment Analysis
5.1. Global genomic biomarkers market: Indication overview
5.1.1. Global genomic biomarkers market revenue share, by Indication, 2016 and 2022
5.2. Oncology
5.2.1. Global genomic biomarkers market for Oncology, 2014 2022 (USD Billion)
5.3. Cardiovascular Diseases
5.3.1. Global genomic biomarkers market for Cardiovascular Diseases, 2014 2022 (USD Billion)
5.4. Neurological Diseases
5.4.1. Global genomic biomarkers market for Neurological Diseases, 2014 2022 (USD Billion)
5.5. Other indications
5.5.1. Global genomic biomarkers market for Other indications, 2014 2022 (USD Billion)
Chapter 6. Global Genomic Biomarkers Market End User Segment Analysis
6.1. Global genomic biomarkers market: End User overview
6.1.1. Global genomic biomarkers market revenue share, by End User, 2016 and 2022
6.2. Hospitals
6.2.1. Global genomic biomarkers market for hospitals, 2014 2022 (USD Billion)
6.3. Diagnostic Research Laboratories
6.3.1. Global genomic biomarkers market for Diagnostic Research Laboratories, 2014 2022 (USD Billion)
6.4. Other End Users
6.4.1. Global genomic biomarkers market for other end users, 2014 2022 (USD Billion)
Chapter 7. Global Genomic biomarkers Market Regional Segment Analysis
7.1. Global genomic biomarkers market: Regional overview
7.1.1. Global genomic biomarkers market revenue share, by region, 2016 and 2022
7.2. North America
7.2.1. North America genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.2.2. North America Genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.2.3. U.S.
7.2.3.1. U.S. genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.2.3.2. U.S. genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.2.4. Canada
7.2.4.1. Canada genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.2.4.2. Canada genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.2.5. Rest of North America
7.2.5.1. Rest of North America genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.2.5.2. Rest of North America genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.3. Europe
7.3.1. Europe genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.3.2. Europe genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.3.3. U.K.
7.3.3.1. U.K. genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.3.3.2. U.K. genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.3.4. Germany
7.3.4.1. Germany genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.3.4.2. Germany genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.3.5. France
7.3.5.1. France genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.3.5.2. France genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.3.6. Italy
7.3.6.1. Italy genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.3.6.2. Italy genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.3.7. Spain
7.3.7.1. Spain genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.3.7.2. Spain genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.3.8. Russia
7.3.8.1. Russia genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.3.8.2. Russia genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.3.9. Rest of Europe
7.3.9.1. Rest of Europe genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.3.9.2. Rest of Europe genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.4.2. Asia Pacific Genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.4.3. China
7.4.3.1. China genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.4.3.2. China genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.4.4. Japan
7.4.4.1. Japan genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.4.4.2. Japan genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.4.5. India
7.4.5.1. India genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.4.5.2. India genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.4.6. Australia
7.4.6.1. Australia genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.4.6.2. Australia genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.4.7. Rest of Asia Pacific
7.4.7.1. Rest of Asia Pacific genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.4.7.2. Rest of Asia Pacific genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.5. Latin America
7.5.1. Latin America Genomic biomarkers market revenue, by indication, 2014 2022(USD Billion)
7.5.2. Latin America Genomic biomarkers market revenue, by end user, 2014 2022(USD Billion)
7.5.3. Brazil
7.5.3.1. Brazil genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.5.3.2. Brazil genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.5.4. Mexico
7.5.4.1. Mexico genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.5.4.2. Mexico genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.5.5. Argentina
7.5.5.1. Argentina genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.5.5.2. Argentina genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.5.6. Rest of Latin America
7.5.6.1. Rest of Latin America genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.5.6.2. Rest of Latin America genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.6.2. Middle East and Africa genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.6.3.2. Saudi Arabia genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.6.4. UAE
7.6.4.1. UAE genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.6.4.2. UAE genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.6.5. South Africa
7.6.5.1. South Africa genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.6.5.2. South Africa genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.6.6. Qatar
7.6.6.1. Qatar genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.6.6.2. Qatar genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
7.6.7. Rest of Middle East and Africa
7.6.7.1. Rest of Middle East and Africa genomic biomarkers market revenue, by indication, 2014 2022 (USD Billion)
7.6.7.2. Rest of Middle East and Africa genomic biomarkers market revenue, by end user, 2014 2022 (USD Billion)
Chapter 8. Company Profile
8.1. Thermo Fisher Scientific
8.1.1. Overview
8.1.2. Financials
8.1.3. Therapy portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. Roche Diagnostics
8.2.1. Overview
8.2.2. Financials
8.2.3. Therapy portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. Myriad Genetics
8.3.1. Overview
8.3.2. Financials
8.3.3. Therapy portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. QIAGEN
8.4.1. Overview
8.4.2. Financials
8.4.3. Therapy portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. Bio-Rad Laboratories
8.5.1. Overview
8.5.2. Financials
8.5.3. Therapy portfolio
8.5.4. Business strategy
8.5.5. Recent developments
8.6. US Biomarkers Inc.
8.6.1. Overview
8.6.2. Financials
8.6.3. Therapy portfolio
8.6.4. Business strategy
8.6.5. Recent developments
8.7. Almac Group
8.7.1. Overview
8.7.2. Financials
8.7.3. Therapy portfolio
8.7.4. Business strategy
8.7.5. Recent developments
8.8. Epigenomics AG
8.8.1. Overview
8.8.2. Financials
8.8.3. Therapy portfolio
8.8.4. Business strategy
8.8.5. Recent developments
